📋 Tender Overview
The subject of this publication is the conclusion of non-exclusive discount agreements for medicines containing the active ingredient testosterone (ATC code according to WHO: G03BA03), restricted to the dosage form gel (sachet) in potencies of 50 mg and 16.2 mg. The contract is concluded within the framework of an open house model, meaning that the contract is open to all interested pharmaceutical companies that meet the participation requirements. Individual contract negotiations will not be conducted, and there is no delivery exclusivity. The purchase quantity is unknown and depends on demand, the number of insured individuals, the prescribing behavior of doctors, and the dispensing behavior of public pharmacies. Minimum purchase quantities are not guaranteed. Testosterone gel (sachet), 50 mg, 16.2 mg